Walgreens Boots Alliance recently reported a quarterly loss that was better than expected, with rising pharmacy sales indicating a potential financial turnaround under new private equity ownership. Sycamore Partners is set to acquire Walgreens for $10 billion, with analysts anticipating increased cost-cutting measures once the deal is finalized later this year. Shareholders are set to vote on the acquisition at a special meeting on July 11, with no significant opposition to the purchase thus far.
The acquisition by Sycamore Partners includes a significant premium of 29% above the stock price in December. Additionally, shareholders will have the opportunity to receive cash from the future monetization of Walgreens’ interests in VillageMD, a primary care business that includes Village Medical, Summit Health, and CityMD. Despite reporting a net loss of $175 million in the third quarter, Walgreens saw a 7% increase in total sales, reaching $39 billion.
CEO Tim Wentworth highlighted improvements in the U.S. Healthcare segment, which includes Village Medical, Summit, and CityMD. The segment reported $2.1 billion in sales for the third quarter, with an operating loss of $64 million, a substantial improvement from the previous year. Analysts praised Walgreens for generating positive free cash flow in the quarter, a significant achievement given recent trends.
The decision to go private under Sycamore Partners’ ownership is seen as a strategic move to allow for reinvention without the pressure of quarterly earnings reports. Walgreens has been actively closing underperforming stores as part of its cost-saving initiatives, with plans to shut down a total of 1,200 stores by fiscal 2027. The company has already closed over 400 stores in the first nine months of the fiscal year and aims to close an additional 500 by the end of the current fiscal year.
The move to private ownership is expected to provide Walgreens with the flexibility needed for long-term growth and innovation, free from the constraints of public market expectations. With the acquisition by Sycamore Partners on the horizon, Walgreens is poised for a new chapter under private equity ownership, positioning the company for a successful financial turnaround.
